Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05307640
Other study ID # 2020-1198
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 16, 2021
Est. completion date April 30, 2025

Study information

Verified date March 2024
Source University of Cincinnati
Contact Emily Werff
Phone 513-307-2963
Email werffel@ucmail.uc.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

After injury, survivors of msTBI depend on informal family caregivers. Upwards of 77% of family caregivers experience poor outcomes, such as adverse life changes, poor health related quality of life, and increased depressive symptoms. Caregivers frequently report minimal support or training to prepare them for their new role. Periods of care transitions, such as ICU discharge, are most difficult. The majority (93%) of previously developed caregiver and caregiver/survivor dyad interventions after msTBI focus on providing information or practical skills to either survivors, or to long-term caregivers (>6 months post injury), rather than education, support, and skill-building that the new caregiver may use proactively that will benefit the dyad acutely after injury. The Aims of this proposal are to: (1) Determine feasibility, satisfaction, and data trends of CG-Well; and (2) Understand how baseline psychosocial risk factors affect response to CG-Well compared to an Information, Support, and Referral control group. To accomplish this, I will first enroll 6-10 caregivers and tailor CG-well until each finds the intervention acceptable, appropriate, and feasible. I will then enroll 100 (50/group) dyads and determine satisfaction ratings, recruitment, retention, and treatment fidelity of CG-Well. Additionally, I will determine if caregivers report reductions in depressive symptoms and improvements in life changes as a result of improvements in task difficulty and threat appraisal in CG-Well compared to ISR at six months. Information obtained in Aims 1 and 2 will be used to plan a larger Phase III trial of CG-Well. Completing these Aims and the training plan will improve outcomes of caregivers and downstream outcomes of survivors of msTBI, and provide me with the skillset necessary to become an independent researcher who can develop and test high-impact, high-fidelity, sustainable interventions.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date April 30, 2025
Est. primary completion date April 30, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion criteria: - Survivor and caregiver =18 years old - Survivor GCS 3-12 after resuscitation - Survivor < 2 weeks post injury - English Speaking - survivor and caregiver Exclusion criteria: - Patient not expected to survive. - Pregnant - survivor or caregiver - Prisoner - survivor or caregiver - History of pre-existing condition that would interfere with follow-up in caregiver or survivor (e.g., substance abuse, alcoholism, end-stage cancers) - Major prior debilitating neurological or mental health disorder in caregiver or survivor (e.g., schizophrenia, bipolar, stroke, dementia).

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
CG-Well
CG-Well is a web & phone based psychosocial intervention that teaches caregivers how to obtain information, education & support
Information Support & Referral (ISR)
Attention control group that receives phone calls and modules from the Brain Injury Association of America.

Locations

Country Name City State
United States University of Cincinnati Cincinnati Ohio

Sponsors (2)

Lead Sponsor Collaborator
Natalie Kreitzer Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Intervention Satisfaction Scale Title: Caregiver Intervention Satisfaction Scale. Likert's scale of usability, ease of use, and acceptability of INR or CG-Well A higher score indicates greater satisfaction; 1-5 scale (strongly disagree=1; strongly agree=5) 6 months
Secondary Brief Symptom Inventory-18 (BSI-18) Quantifies symptoms of somatization, depression, and anxiety. The BSI-18 consists of 18 items on a 5-point (0-4) Likert scale and is designed to assess current psychological distress (over the past 7 days). In addition to a total score, referred to as the Global Severity Index (GSI; max = 72), a separate score can be calculated on a depressive subscale: with six questions contributing to the subscale (max = 24). Raw scores will be converted to t-scores. Higher scores reflect greater distress. 6 months
Secondary Bakas Caregiver Outcomes Scale (BCOS) Measures life changes specifically resulting from providing care, such as negative social, emotional, health-related, financial wellbeing, level of energy, and role functioning effects. Each change is rated on a seven-point Likert scale (-3=changed for the worst to +3=changed for the best). 6 months
Secondary Oberst Caregiving Burden Scale Measures time and difficulty associated with caregiving tasks, such as providing personal care, managing emotions of the TBI survivor, and dealing with finances. Task difficulty is measured on a seven-point Likert scale (-3 extremely difficult to +3 extremely easy), and time is rated on a five-point Likert scale (5 = great amount, 1 = none). 6 months
Secondary Appraisal of Caregiving Scale Threat Subscale Measures the caregiver appraisal of their current situation (threat and worry) by focusing on perceived threat. The ACS uses a five-point Likert scale to determine stress in the current situation (5 = strongly agree, 1 = strongly disagree). 6 months
Secondary Feasibility of CG-Well (Recruitment) Measurements of recruitment: Will look at how many caregivers were approached vs. consented. up to 30 months
Secondary Feasibility of CG-Well (Retention) Measurements of Retention: Will look at how many caregivers were still active in the study at the 6 month mark. 6 months
Secondary Feasibility of CG-Well (Treatment Fidelity) Measurements of Treatment Fidelity: We will report the proportion of participants who have all elements of fidelity checklist (Borrelli Treatment Fidelity Checklist: Checklist makes sure the following is completed: Standardized research coordinator training, Documentation of study activity at each session, Audio recorded calls, PI, mentor and third party coordinator review 20% of recorded sessions and Team meetings to discuss treats to fidelity.
These checklists are reviewed on a weekly basis.
up to 36 months
Secondary Feasibility of CG-Well (Number of Log Ins to the website) Participant reported number of times they log into the study website each month.
Reported during study visit calls.
up to 36 months
Secondary Feasibility of CG-Well (Time that the participant spent in modules) Participant reported length of time spent each month on the website or in modules.
Reported during study visit calls.
up to 36 months
Secondary Feasibility of CG-Well (Time spent in monthly phone calls with the study team) Study phone calls are recorded and time stamped. up to 36 months
See also
  Status Clinical Trial Phase
Completed NCT04527289 - Impact of Amantadine on Traumatic Brain Injury Phase 4
Completed NCT04624152 - The Role of Hypoxia on Subconcussive Head Impacts N/A
Active, not recruiting NCT04176640 - Quantifying Brain Injury on Computed Tomography in Hospitalized Children
Completed NCT05195996 - Beta Blocker Effects in Traumatic Brain Injury Phase 4
Completed NCT03648476 - Intervention to Change Attributions That Are Negative (ICAN) N/A
Not yet recruiting NCT05129514 - Imaging Lymphatic/Cerebrospinal Fluid (CSF) Drainage From the Head and Neck in Persons With Traumatic Brain Injury: Demonstration of Feasibility and Evaluation of Manual Therapy to Improve Drainage and Facilitate Cognitive Recovery N/A
Completed NCT04397952 - Endotracheal Tube Cuff Pressure Measurement
Not yet recruiting NCT06057155 - Intracranial Pressure and Optic Nerve Sheath Diameter With CLOSED Bundle
Not yet recruiting NCT05818371 - Non-invasive ONSD-based Neuromonitoring in a Neurointensive Care Setting N/A
Not yet recruiting NCT03839381 - Turkish Version of Mini-BESTest, Validity and Reliability for Adult Participants With Sensoriomotor Impairments
Recruiting NCT06027411 - Assess the Clinical Effectiveness in AI Prioritising CT Heads
Recruiting NCT05151978 - Transcranial Doppler in Mild and Moderate Traumatic Brain Injury (TBI)
Recruiting NCT04051528 - Do Combinatorial Training Lead to Better Cognition and Daily Participation in TBI Persons With Cognitive Impairments N/A
Recruiting NCT06028906 - Research of Optimal Cerebral Perfusion Pressure Diagnosis
Recruiting NCT06083441 - SeeMe: An Automated Tool to Detect Early Recovery After Brain Injury
Recruiting NCT03344432 - Correlation Intraocular Pressure With Intracranial Pressure N/A
Recruiting NCT04926987 - The Research of Human Cortex Cell Atlas
Recruiting NCT05726201 - (POCUS) As an Early Screening Tool for Diagnosing Skull Fractures in Children
Active, not recruiting NCT04564495 - Home Based Tele-exercise for People With Chronic Neurological Impairments N/A
Active, not recruiting NCT04058379 - Artificial Intelligence Analysis of Initial Scan Evolution of Traumatic Brain Injured Patient to Predict Neurological Outcome N/A